DermTech Overview
Compare DermTech's DCF valuation ($12) to today's market price.
Get informed when a big investor buys or sells
+ Follow$11.69
Undervalued by 12333.4% based on the discounted cash flow analysis.
DermTech (DMTK) currently reports a DCF fair value of $12. Use the charts on this page to explore DermTech's DCF fair value history and peer comparisons.
DermTech's discounted cash flow (DCF) fair value estimate is $12, about 12333.4% undervalued versus the current market price. DCF models project future free cash flows and discount them back to today — so the result depends on growth, margin, and discount-rate assumptions. Use it as one valuation lens alongside multiples and peer checks on Stockcircle.
Start with the current DCF fair value of $12, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for DermTech, and consider following DMTK for alerts when major investors trade the stock.
DermTech is classified in the Healthcare sector. On DCF fair value, it currently shows $12. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DMTK with unrelated industries.
